Athira Pharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Athira Pharma Stock Summary

Athira Pharma competes with CytomX Therapeutics, Spero Therapeutics, Instil Bio, NextCure, and Assembly Biosciences. Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company was incorporated in 2011 and is headquartered in Bothell, Washington. Athira Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Athira Pharma Key Financial Ratios

Athira Pharma Key Balance Sheet Accounts

Athira Pharma Key Income Statement Accounts

Athira Pharma Key Cash Accounts

Athira Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Athira Pharma's current stock value. Our valuation model uses many indicators to compare Athira Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Athira Pharma competition to find correlations between indicators driving Athira Pharma's intrinsic value. More Info.Athira Pharma is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Athira Pharma's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Athira Pharma's earnings, one of the primary drivers of an investment's value.

Athira Pharma Systematic Risk

Today, most investors in Athira Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Athira Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Athira Pharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Athira Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Athira Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Athira Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Athira Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Athira Pharma's daily price indicators and compare them against related drivers.

When running Athira Pharma's price analysis, check to measure Athira Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athira Pharma is operating at the current time. Most of Athira Pharma's value examination focuses on studying past and present price action to predict the probability of Athira Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athira Pharma's price. Additionally, you may evaluate how the addition of Athira Pharma to your portfolios can decrease your overall portfolio volatility.